Abstract:OBJECTIVE: To determine the methylation levels of CpGs in the GPX3 promoter region and explore their potential effects on the apoptosis of chondrocytes.METHODS: Blood specimens were collected from 32 participants; 16 KBD patients and 16 healthy subjects. Twenty-five CpGs in the promoter region of GPX3 were identified and detected by MALDI-TOF-MS. Methylation levels of CpGs were compared between KBD patients and healthy subjects as well as among the KBD patients with different degrees. C28/I2 human chondrocytes were treated with tBHP and Na2SeO3. Apoptosis in chondrocytes was examined under a fluorescence microscope.RESULTS: The methylation levels of GPX3-1_CpG_11 and GPX3-1_CpG_16 in KBD patients were significantly higher than those of healthy subjects (P < 0.05). The methylation levels of the other CpGs were not significantly different between the two groups (P > 0.05). The methylation level of GPX3-1_CpG_24 in KBD patients was significantly higher than those of healthy subjects (P < 0.05). MSP-PCR analysis indicated that the methylation rate of KBD group (9.41%) was significantly higher than that of healthy subjects (1.18%), and that GPX3 DNA methylation increased the risk of acquiring KBD 8 fold (OR = 8.000, 95% CI: 1.023-62.580); The mRNA expression of GPX3 in whole blood of KBD patients was lower than that of healthy subjects (P<0.05); Compared with the control group, GPX3, GPX1 and GPX4 mRNA level of the tertbutyl hydroperoxide injury group decreased significantly (P < 0.05), after supplementation with Na2SeO3. The rate of chondrocytes apoptosis was decreased with the increasing of GPX3 and GPX4 mRNA levels (P<0.05) and GPX3 mRNA showed a similar trend without statistically significant (P>0.05).CONCLUSION: The methylation patterns of CpGs in GPX3 varied in KBD patients. The experiments indicated that the increased methylation of CpGs within the GPX3 promoter may down-regulate the expression of GPX3, thereby reducing the antioxidant function of GPX3 and promoting chondrocyte apoptosis, both of which accelerates the occurrence of KBD. We therefore propose a new understanding of GPX3's potential epigenetic and genetic mechanisms that contribute to KBD.

Patients with Osteoarthritis and Kashin-Beck Disease Display Distinct CpG Methylation Profiles in the DIO2, GPX3 , and TXRND1 Promoter Regions

Crosstalk Between CpG Methylation and Polymorphisms (Cpg-Snps) in the Promotor Region of DIO2 in Kashin-Beck Disease.

Genome-wide DNA Methylation Profiling of Articular Cartilage Reveals Significant Epigenetic Alterations in Kashin-Beck Disease and Osteoarthritis

Genome-Wide Differentially Methylated Region Analysis to Reveal Epigenetic Differences of Articular Cartilage in Kashin–Beck Disease and Osteoarthritis

Comprehensive comparative analysis of histopathology and gene expression in subchondral bone between kashin-beck disease and primary osteoarthritis

CpG methylation of the GPX3 promoter in patients with Kashin-Beck Disease potentially promotes chondrocyte apoptosis

Effects of Methylation of Deiodinase 3 Gene on Gene Expression and Severity of Kashin–Beck Disease

Integrating Genome-Wide DNA Methylation and Mrna Expression Profiles Identified Different Molecular Features Between Kashin-Beck Disease and Primary Osteoarthritis.

Identification of cell-specific epigenetic patterns associated with chondroitin sulfate treatment response in an endemic arthritis, Kashin-Beck disease

Integrative Analysis of Genome-Wide Association Studies and DNA Methylation Profile Identified Genetic Control Genes of DNA Methylation for Kashin-Beck Disease

The Integrative Analysis of DNA Methylation and Mrna Expression Profiles Confirmed the Role of Selenocompound Metabolism Pathway in Kashin-Beck Disease.

Comparative Analysis of Gene Expression Profiles Between Primary Knee Osteoarthritis and an Osteoarthritis Endemic to Northwestern China, Kashin-Beck Disease

Transcriptome‐wide RNA m6A methylation profiles in an endemic osteoarthropathy, Kashin‐Beck disease

Association study between polymorphisms in selenoprotein genes and susceptibility to Kashin-Beck disease

Identification of differentially expressed genes and pathways between primary osteoarthritis and endemic osteoarthritis (Kashin-Beck disease).

Exploring Genome-wide DNA Methylation Profiles Altered in Kashin-Beck Disease Using Infinium Human Methylation 450 Bead Chips.

Comparative Analysis of Signaling Pathways in Peripheral Blood from Patients with Kashin-Beck Disease and Osteoarthritis.

ATAC-seq Reveals the Roles of Chromatin Accessibility in the Chondrocytes of Kashin–Beck Disease Compared with Primary Osteoarthritis

Difference in Apoptosis-Associated Genes Expression Profiling and Immunohistology Analysis Between Kashin-Beck Disease and Primary Osteoarthritis

Combined Bioinformatics Analysis Reveals Gene Expression and DNA Methylation Patterns in Osteoarthritis.

Analysis of Gene Expression and Methylation Datasets Identified ADAMTS9, FKBP5, and PFKBF3 As Biomarkers for Osteoarthritis.